-
J&J shot approved by FDA; 1 dose of Pfizer's shot may protect survivors and more: 5 COVID-19 vaccine updates
Here are five updates on the COVID-19 vaccine over the past week: -
3 Ways ASCs Can Incorporate 2021 CMS Updates
As the inpatient only (IPO) list is phased out over the next three years, Ambulatory Surgery Center (ASC) leaders face increasing pressure to adapt and make solid decisions that balance financial health, patient needs, and provider expectations. -
Short trials OK for shots against variants, Pfizer begins testing in pregnant women and more — 5 updates on the COVID-19 vaccine
Here are five updates on the COVID-19 vaccine over the past week: -
Orthopedic companies vie for ASC business: Stryker, Johnson & Johnson, Smith+Nephew & Zimmer Biomet's approach
Four large orthopedic device companies have launched ASC-specific services over the past year and continue to see outpatient surgery as important to their business strategy. -
Supply Chain Tip of the Week: Cut freight costs by tracking key benchmarks with a freight management program
Freight costs can be measured and managed with the data analytics tools of a freight management program. To monitor ongoing performance, track such key metrics as shipping rates, shipping modes and handling fees. -
US buys 200M more doses, Moderna can boost vial volume by 40% and more — 5 updates on the COVID-19 vaccine
Here are five updates on the COVID-19 vaccine over the past week: -
Amazon's healthcare moves: 7 notes for ASCs and physicians
Amazon is a big force in healthcare and has made significant changes in the past 12 months that could affect physician practices and ASCs. -
AstraZeneca's shot may reduce virus transmission; drugmakers partner to combat multiple variants and more — 5 updates on the COVID-19 vaccine
Here are five updates on the COVID-19 vaccine over the past week: -
Supply Chain Tip of the Week: Supply chain can impact staff satisfaction- make sure the impact is positive
In the current healthcare climate, it’s vital for ASCs to attract and retain top talent in order to remain competitive. -
113 drug shortages in the US
As of Feb. 4, the FDA lists 113 drugs as being in short supply. -
Kaiser would need 4+ years to vaccinate Californians; U.S. to send 1M doses to pharmacies next month & more — 7 updates on the COVID-19 vaccine
Here are seven updates about the COVID-19 vaccine over the past week: -
4 things ASCs need to know about outpatient cardiovascular procedures
Now that CMS has approved reimbursement for percutaneous coronary interventions (PCIs), among other cardiovascular procedures, in the ambulatory surgery center (ASC) setting, Medicare-accredited surgery centers around the country are deciding what part PCI should play in their organization. -
3 major supply chain concerns for ASC leaders
The COVID-19 pandemic threw curveballs in existing supply chain issues for ASCs. Here are three of the biggest concerns ASC leaders have shared over the past 90 days: -
Stryker sets sights on ASCs for 2021
In 2020, Stryker launched its ASC sales model to leverage the company's portfolio for the outpatient setting. -
Testing in children, effectiveness against new variants and more — 6 updates on the COVID-19 vaccine, antibody drugs
Here are six updates on the COVID-19 vaccine and antibody drugs over the past week: -
Supply Chain Tip of the Week: Adapt your quality auditing process
Many facilities may not have a dedicated QI staff member in charge of educating staff about procedures and products that support compliance. -
The top ASC supply chain issues? Allocation, allocation, allocation
Danilo D'Aprile, administrator of Orthopaedic & Specialty Surgery Center in Danbury, Conn., joined the Becker's Ambulatory Surgery Centers podcast to share his goals for 2021 and discuss his top supply chain issues. -
Remote monitoring will be key to the evolution of cardiovascular monitoring
GlobalData believes remote monitoring will accelerate the cardiovascular disease treatment market going forward. -
Johnson & Johnson falling behind schedule, the main errors in doses and more — 5 updates on the COVID-19 vaccine
Here are five updates on the COVID-19 vaccine over the past week: -
Pfizer effective against new strain; Bayer supports CureVac and more — 4 updates on the COVID-19 vaccine, antibody drugs
Here are four updates about the COVID-19 vaccine and antibody drugs over the past week:
Page 15 of 65